Order Article Reprints

Liposits G, Skuladottir H, Ryg J, Winther SB, Möller S, Hofsli E, Shah C-H, Poulsen LØ, Berglund Å, Qvortrup C, et al. The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy—The Randomized NORDIC9-Study. Journal of Clinical Medicine. 2022; 11(19):5603. https://doi.org/10.3390/jcm11195603

Liposits, Gabor, Halla Skuladottir, Jesper Ryg, Stine Brændegaard Winther, Sören Möller, Eva Hofsli, Carl-Henrik Shah, Laurids Østergaard Poulsen, Åke Berglund, Camilla Qvortrup, and et al. 2022. "The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy—The Randomized NORDIC9-Study" Journal of Clinical Medicine 11, no. 19: 5603. https://doi.org/10.3390/jcm11195603

Liposits, G., Skuladottir, H., Ryg, J., Winther, S. B., Möller, S., Hofsli, E., Shah, C.-H., Poulsen, L. Ø., Berglund, Å., Qvortrup, C., Osterlund, P., Johansen, J. S., Glimelius, B., Sorbye, H., & Pfeiffer, P. (2022). The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy—The Randomized NORDIC9-Study. Journal of Clinical Medicine, 11(19), 5603. https://doi.org/10.3390/jcm11195603